Evidence map›Paper›PMID 36999476›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2023

Progress in the application of patch materials in cardiovascular surgery.

Rubing Shao, Jiehua Li, Lunchang Wang, Xin Li, Chang Shu

Open access · greenAbstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rubing ShaoDepartment of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. 2204170208@csu.edu.cn.
Jiehua LiDepartment of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011.
Lunchang WangDepartment of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011.
Xin LiDepartment of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. lixin1981@csu.edu.cn.
Chang ShuDepartment of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. shuchang@csu.edu.cn.
Central South University · CN

Funding

the National Natural Science Foundation of China 82120108005
6 · The paper itself

Abstract

The cardiovascular patch, served as artificial graft materials to replace heart or vascular tissue defect, is still playing a key role in cardiovascular surgeries. The defects of traditional cardiovascular patch materials may determine its unsatisfactory long-term effect or fatal complications after surgery. Recent studies on many new materials (such as tissue engineered materials, three-dimensional printed materials, etc) are being developed. Patch materials have been widely used in clinical procedures of cardiovascular surgeries such as angioplasty, cardiac atrioventricular wall or atrioventricular septum repair, and valve replacement. The clinical demand for better cardiovascular patch materials is still urgent. However, the cardiovascular patch materials need to adapt to normal coagulation mechanism and durability, promote short-term endothelialization after surgery, and inhibit long-term postoperative intimal hyperplasia, its research and development process is relatively complicated. Understanding the characteristics of various cardiovascular patch materials and their application in cardiovascular surgeries is important for the selection of new clinical surgical materials and the development of cardiovascular patch materials.

Indexed as

Cardiac Surgical ProceduresHeart AtriaHeart VentriclesTissue EngineeringTreatment Outcomebiomaterialscardiovascular surgerypatch materialstissue engineering materials

Identifiers

PMID36999476
PMCPMC10930349
OpenAlexW4362505722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.